Clinical Trials
5 trialsNCT06893354 2025-03-25
Explore the Mechanisms Underlying Disease Resistance and Potential Primary Resistance Mechanism of Induction Therapy Lorlatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Positive Mutation Revealed by Single-cell RNA Sequencing and Spatial Transcriptomics
The First Affiliated Hospital of Guangzhou Medical University
Phase 4 Not yet recruiting
NCT05387109 2022-05-24
pcwaintrl
Tang-Du Hospital
Phase 4 Unknown
NCT03986528 2021-02-23
Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase 4 Unknown
NCT03799601 2019-01-10
ALTER-L013
Tongji Hospital
Phase 4 Unknown
NCT02778893 2016-05-20
Conmana Combined With Thalidomide to Treat NSCLC
Henan Provincial People's Hospital
Phase 4 Unknown